| Sarah Lynn Patterson, | |
|
505 Parnassus Ave, San Francisco, CA 94143-0119 | |
| (415) 476-1528 | |
| Not Available |
| Full Name | Sarah Lynn Patterson |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 18 Years |
| Location | 505 Parnassus Ave, San Francisco, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346531175 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | A123829 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ucsf Medical Center | San francisco, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Regents Of The University Of California | 4284547274 | 563 |
| Ucsf Medical Group Business Services | 3779497870 | 1064 |
| University Of California San Francisco | 4486567229 | 1298 |
News Archive
In the treatment of multiple myeloma, the addition of carfilzomib to a currently accepted two-drug combination produced significantly better results than using the two drugs alone, according to a worldwide research team led by investigators from Mayo Clinic.
Lycera Corporation, a biopharmaceutical company pioneering an innovative approach to developing novel oral medicines to treat autoimmune diseases, today announced that the company has made important progress, triggering a second tranche of $11 million in its Series A financing. Proceeds from the second tranche will be used to continue to advance Lycera's discovery and development efforts and further support the growth of the company.
A new study reveals that young adults who take oral antibiotics for acne may be more likely to get sore throats. The reason behind this is unclear say researchers. However they add that long-term use of antibiotics might change the balance of bacteria in the throat. In principle, that could allow infection-causing strains to multiply.
For the eighth consecutive time, Rush University Medical Center has received an "A" for patient safety in a nationwide evaluation of hospitals by the Leapfrog Group. Rush has received an A, the top grade possible, each time the Leapfrog Group has rated hospitals since launching the organization's Hospital Safety Score in June 2012.
Mesenchymal stem cells (MSCs) are bone marrow-derived cells that are capable of giving rise to various cell types through a process known as differentiation.
› Verified 8 days ago
| Entity Name | Regents Of The University Of California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881763597 PECOS PAC ID: 4284547274 Enrollment ID: O20031106000389 |
News Archive
In the treatment of multiple myeloma, the addition of carfilzomib to a currently accepted two-drug combination produced significantly better results than using the two drugs alone, according to a worldwide research team led by investigators from Mayo Clinic.
Lycera Corporation, a biopharmaceutical company pioneering an innovative approach to developing novel oral medicines to treat autoimmune diseases, today announced that the company has made important progress, triggering a second tranche of $11 million in its Series A financing. Proceeds from the second tranche will be used to continue to advance Lycera's discovery and development efforts and further support the growth of the company.
A new study reveals that young adults who take oral antibiotics for acne may be more likely to get sore throats. The reason behind this is unclear say researchers. However they add that long-term use of antibiotics might change the balance of bacteria in the throat. In principle, that could allow infection-causing strains to multiply.
For the eighth consecutive time, Rush University Medical Center has received an "A" for patient safety in a nationwide evaluation of hospitals by the Leapfrog Group. Rush has received an A, the top grade possible, each time the Leapfrog Group has rated hospitals since launching the organization's Hospital Safety Score in June 2012.
Mesenchymal stem cells (MSCs) are bone marrow-derived cells that are capable of giving rise to various cell types through a process known as differentiation.
› Verified 8 days ago
| Entity Name | University Of California San Francisco |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861578973 PECOS PAC ID: 4486567229 Enrollment ID: O20031212000897 |
News Archive
In the treatment of multiple myeloma, the addition of carfilzomib to a currently accepted two-drug combination produced significantly better results than using the two drugs alone, according to a worldwide research team led by investigators from Mayo Clinic.
Lycera Corporation, a biopharmaceutical company pioneering an innovative approach to developing novel oral medicines to treat autoimmune diseases, today announced that the company has made important progress, triggering a second tranche of $11 million in its Series A financing. Proceeds from the second tranche will be used to continue to advance Lycera's discovery and development efforts and further support the growth of the company.
A new study reveals that young adults who take oral antibiotics for acne may be more likely to get sore throats. The reason behind this is unclear say researchers. However they add that long-term use of antibiotics might change the balance of bacteria in the throat. In principle, that could allow infection-causing strains to multiply.
For the eighth consecutive time, Rush University Medical Center has received an "A" for patient safety in a nationwide evaluation of hospitals by the Leapfrog Group. Rush has received an A, the top grade possible, each time the Leapfrog Group has rated hospitals since launching the organization's Hospital Safety Score in June 2012.
Mesenchymal stem cells (MSCs) are bone marrow-derived cells that are capable of giving rise to various cell types through a process known as differentiation.
› Verified 8 days ago
| Entity Name | Ucsf Medical Group Business Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477624104 PECOS PAC ID: 3779497870 Enrollment ID: O20040622001513 |
News Archive
In the treatment of multiple myeloma, the addition of carfilzomib to a currently accepted two-drug combination produced significantly better results than using the two drugs alone, according to a worldwide research team led by investigators from Mayo Clinic.
Lycera Corporation, a biopharmaceutical company pioneering an innovative approach to developing novel oral medicines to treat autoimmune diseases, today announced that the company has made important progress, triggering a second tranche of $11 million in its Series A financing. Proceeds from the second tranche will be used to continue to advance Lycera's discovery and development efforts and further support the growth of the company.
A new study reveals that young adults who take oral antibiotics for acne may be more likely to get sore throats. The reason behind this is unclear say researchers. However they add that long-term use of antibiotics might change the balance of bacteria in the throat. In principle, that could allow infection-causing strains to multiply.
For the eighth consecutive time, Rush University Medical Center has received an "A" for patient safety in a nationwide evaluation of hospitals by the Leapfrog Group. Rush has received an A, the top grade possible, each time the Leapfrog Group has rated hospitals since launching the organization's Hospital Safety Score in June 2012.
Mesenchymal stem cells (MSCs) are bone marrow-derived cells that are capable of giving rise to various cell types through a process known as differentiation.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sarah Lynn Patterson, 400 Parnassus Ave, San Francisco, CA 94143-2202 Ph: (415) 353-2797 | Sarah Lynn Patterson, 505 Parnassus Ave, San Francisco, CA 94143-0119 Ph: (415) 476-1528 |
News Archive
In the treatment of multiple myeloma, the addition of carfilzomib to a currently accepted two-drug combination produced significantly better results than using the two drugs alone, according to a worldwide research team led by investigators from Mayo Clinic.
Lycera Corporation, a biopharmaceutical company pioneering an innovative approach to developing novel oral medicines to treat autoimmune diseases, today announced that the company has made important progress, triggering a second tranche of $11 million in its Series A financing. Proceeds from the second tranche will be used to continue to advance Lycera's discovery and development efforts and further support the growth of the company.
A new study reveals that young adults who take oral antibiotics for acne may be more likely to get sore throats. The reason behind this is unclear say researchers. However they add that long-term use of antibiotics might change the balance of bacteria in the throat. In principle, that could allow infection-causing strains to multiply.
For the eighth consecutive time, Rush University Medical Center has received an "A" for patient safety in a nationwide evaluation of hospitals by the Leapfrog Group. Rush has received an A, the top grade possible, each time the Leapfrog Group has rated hospitals since launching the organization's Hospital Safety Score in June 2012.
Mesenchymal stem cells (MSCs) are bone marrow-derived cells that are capable of giving rise to various cell types through a process known as differentiation.
› Verified 8 days ago
Dr. Pratyusha Kishore Narra, MBBS Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3490 California St, San Francisco, CA 94118 Phone: 415-514-6200 Fax: 415-514-6410 | |
Dr. Chelsea Joy Thomsen, M.D., M.S.P.H Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2 W Portal Ave, San Francisco, CA 94127 Phone: 415-291-0480 | |
Christine Soran, Rheumatology Medicare: Medicare Enrolled Practice Location: 1001 Potrero Ave, Bldg 10, 3rd Floor, Ward 13, Ucsf Division Of General Internal Medicine Sfgh, San Francisco, CA 94110 Phone: 415-206-5164 Fax: 415-206-5586 | |
Stephen Norris Cohen, MD Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 40 Ventura Ave, San Francisco, CA 94116 Phone: 415-681-2171 Fax: 415-681-2171 | |
Mauricio Jalife Bucay, M.D Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 505 Parnassus Ave, San Francisco, CA 94143 Phone: 415-750-4994 Fax: 415-750-8156 | |
Dr. Adriana A.t. Martin, M.D., PH.D. Rheumatology Medicare: Medicare Enrolled Practice Location: 505 Parnassus Ave, San Francisco, CA 94143 Phone: 415-514-7288 | |
Dr. Alexandra Cristina Villasante Fricke, MD Rheumatology Medicare: Medicare Enrolled Practice Location: 655 Montgomery St Ste 810, San Francisco, CA 94111 Phone: 844-847-8216 Fax: 415-520-9150 |